Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis
about
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatographyComputational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7.Site-directed mutagenesis maps interactions that enhance cognate and limit promiscuous catalysis by an alkaline phosphatase superfamily phosphodiesterase.Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.Physiological functions and clinical implications of sphingolipids in the gut.Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.Metabolic Regulation of Apoptosis in Cancer.Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.Targeting Phospholipid Metabolism in Cancer.Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells.Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied.
P2860
Q34078002-72AB331D-58BA-49DD-960C-9FAE89893694Q34104045-B3D9D38D-52E1-4E8B-BB7A-1FA6EFEADE44Q35558012-8489111E-1057-40F5-BBE3-3447477CF149Q35771158-3BA2A436-7CA7-4641-B084-09307836C857Q37852814-92EEC525-45DF-430C-B2D0-6D10E1DB9735Q38262594-E8502791-B6CC-4296-B4D8-1BA0755BAF89Q38969211-D4944BD9-40E8-4F0E-A5F4-202AD35E492FQ39076259-8F349752-61EE-47BB-A007-1953A0A9F9E0Q39084885-7A7890F2-4B48-4983-9E23-1F668F7FFE8EQ39088175-3C7ED62F-F5F3-4E3C-80F4-4ADCFAABE4A8Q39768734-6EC4BF76-4AD6-4DBF-8C7A-E9D9B632F416Q42971462-3AF6BCEE-F772-4EF9-BEB9-B60F103048DDQ43203205-E9B89CEF-A8C0-4D04-AA89-FBAACD39BE9AQ54937330-FBBC7BFD-A353-4634-950F-FE53B9BF74BC
P2860
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Identification of aberrant for ...... with human liver tumorigenesis
@ast
Identification of aberrant for ...... with human liver tumorigenesis
@en
Identification of aberrant for ...... with human liver tumorigenesis
@nl
type
label
Identification of aberrant for ...... with human liver tumorigenesis
@ast
Identification of aberrant for ...... with human liver tumorigenesis
@en
Identification of aberrant for ...... with human liver tumorigenesis
@nl
prefLabel
Identification of aberrant for ...... with human liver tumorigenesis
@ast
Identification of aberrant for ...... with human liver tumorigenesis
@en
Identification of aberrant for ...... with human liver tumorigenesis
@nl
P2093
P2860
P356
P1476
Identification of aberrant for ...... with human liver tumorigenesis
@en
P2093
E Hertervig
S Lindgren
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604013
P407
P577
2007-11-19T00:00:00Z
P5875
P6179
1026729489